Chemical Formula: C5H10N2O3

Chemical Formula C5H10N2O3

Found 98 metabolite its formula value is C5H10N2O3

L-Glutamine

(2S)-2,5-diamino-5-oxopentanoic acid

C5H10N2O3 (146.069139)


Glutamine (Gln), also known as L-glutamine is an alpha-amino acid. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Amino acids are organic compounds that contain amino (–NH2) and carboxyl (–COOH) functional groups, along with a side chain (R group) specific to each amino acid. Structurally, glutamine is similar to the amino acid glutamic acid. However, instead of having a terminal carboxylic acid, it has an amide. Glutamine is one of 20 proteinogenic amino acids, i.e., the amino acids used in the biosynthesis of proteins. Glutamine is found in all organisms ranging from bacteria to plants to animals. It is classified as an aliphatic, polar amino acid. In humans glutamine is considered a non-essential amino acid. Enzymatically, glutamine is formed by replacing a side-chain hydroxyl of glutamic acid with an amine functional group. More specifically, glutamine is synthesized by the enzyme glutamine synthetase from glutamate and ammonia. The most relevant glutamine-producing tissue are skeletal muscles, accounting for about 90\\\\\\% of all glutamine synthesized. Glutamine is also released, in small amounts, by the lungs and brain. In human blood, glutamine is the most abundant free amino acid. Dietary sources of glutamine include protein-rich foods such as beef, chicken, fish, dairy products, eggs, beans, beets, cabbage, spinach, carrots, parsley, vegetable juices, wheat, papaya, Brussels sprouts, celery and kale. Glutamine is one of the few amino acids that can directly cross the blood–brain barrier. Glutamine is often used as a supplement in weightlifting, bodybuilding, endurance and other sports, as well as by those who suffer from muscular cramps or pain, particularly elderly people. In 2017, the U.S. Food and Drug Administration (FDA) approved L-glutamine oral powder, marketed as Endari, to reduce severe complications of sickle cell disease in people aged five years and older with the disorder. Subjects who were treated with L-glutamine oral powder experienced fewer hospital visits for pain treated with a parenterally administered narcotic or ketorolac. The main use of glutamine within the diet of either group is as a means of replenishing the bodys stores of amino acids that have been used during exercise or everyday activities. Studies which have looked into problems with excessive consumption of glutamine thus far have proved inconclusive. However, normal supplementation is healthy mainly because glutamine is supposed to be supplemented after prolonged periods of exercise (for example, a workout or exercise in which amino acids are required for use) and replenishes amino acid stores. This is one of the main reasons glutamine is recommended during fasting or for people who suffer from physical trauma, immune deficiencies, or cancer. There is a significant body of evidence that links glutamine-enriched diets with positive intestinal effects. These include maintenance of gut barrier function, aiding intestinal cell proliferation and differentiation, as well as generally reducing septic morbidity and the symptoms of Irritable Bowel Syndrome (IBS). The reason for such "cleansing" properties is thought to stem from the fact that the intestinal extraction rate of glutamine is higher than that for other amino acids, and is therefore thought to be the most viable option when attempting to alleviate conditions relating to the gastrointestinal tract. These conditions were discovered after comparing plasma concentration within the gut between glutamine-enriched and non glutamine-enriched diets. However, even though glutamine is thought to have "cleansing" properties and effects, it is unknown to what extent glutamine has clinical benefits, due to the varied concentrations of glutamine in varieties of food. It is also known that glutamine has positive effects in reducing healing time after operations. Hospital waiting times after abdominal s... L-glutamine, also known as L-2-aminoglutaramic acid or levoglutamide, is a member of the class of compounds known as L-alpha-amino acids. L-alpha-amino acids are alpha amino acids which have the L-configuration of the alpha-carbon atom. L-glutamine is soluble (in water) and a moderately acidic compound (based on its pKa). L-glutamine can be found in a number of food items such as acorn, yautia, ohelo berry, and oregon yampah, which makes L-glutamine a potential biomarker for the consumption of these food products. L-glutamine can be found primarily in most biofluids, including blood, sweat, breast milk, and cerebrospinal fluid (CSF), as well as throughout most human tissues. L-glutamine exists in all living species, ranging from bacteria to humans. In humans, L-glutamine is involved in several metabolic pathways, some of which include amino sugar metabolism, the oncogenic action of 2-hydroxyglutarate, mercaptopurine metabolism pathway, and transcription/Translation. L-glutamine is also involved in several metabolic disorders, some of which include the oncogenic action of d-2-hydroxyglutarate in hydroxygluaricaciduria, tay-sachs disease, xanthinuria type I, and adenosine deaminase deficiency. Moreover, L-glutamine is found to be associated with carbamoyl Phosphate Synthetase Deficiency, epilepsy, schizophrenia, and alzheimers disease. L-glutamine is a non-carcinogenic (not listed by IARC) potentially toxic compound. L-glutamine is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. L-Glutamine (L-Glutamic acid 5-amide) is a non-essential amino acid present abundantly throughout the body and involved in many metabolic processes. L-Glutamine provides a source of carbons for oxidation in some cells[1][2]. L-Glutamine (L-Glutamic acid 5-amide) is a non-essential amino acid present abundantly throughout the body and involved in many metabolic processes. L-Glutamine provides a source of carbons for oxidation in some cells[1][2]. L-Glutamine (L-Glutamic acid 5-amide) is a non-essential amino acid present abundantly throughout the body and involved in many metabolic processes. L-Glutamine provides a source of carbons for oxidation in some cells[1][2].

   

3-ureido-isobutyrate

3-((Aminocarbonyl)amino)-2-methylpropanoic acid

C5H10N2O3 (146.069139)


Ureidoisobutyric acid, also known as 3-ureidoisobutyrate or beta-uba, is a member of the class of compounds known as ureas. Ureas are compounds containing two amine groups joined by a carbonyl (C=O) functional group. Ureidoisobutyric acid is soluble (in water) and a weakly acidic compound (based on its pKa). Ureidoisobutyric acid can be found in a number of food items such as pili nut, breakfast cereal, bitter gourd, and scarlet bean, which makes ureidoisobutyric acid a potential biomarker for the consumption of these food products. Ureidoisobutyric acid can be found primarily in blood, cerebrospinal fluid (CSF), and urine. Ureidoisobutyric acid exists in all living organisms, ranging from bacteria to humans. In humans, ureidoisobutyric acid is involved in the pyrimidine metabolism. Ureidoisobutyric acid is also involved in few metabolic disorders, which include beta ureidopropionase deficiency, dihydropyrimidinase deficiency, MNGIE (mitochondrial neurogastrointestinal encephalopathy), and UMP synthase deficiency (orotic aciduria). Moreover, ureidoisobutyric acid is found to be associated with beta-ureidopropionase deficiency.

   

Isoglutamine

4,5-Diamino-5-oxopentanoic acid

C5H10N2O3 (146.069139)


   

D-Glutamine

(2R)-2-Amino-4-carbamoylbutanoic acid

C5H10N2O3 (146.069139)


D-Glutamine, also known as DGN or D glutamine, belongs to the class of organic compounds known as d-alpha-amino acids. These are alpha amino acids which have the D-configuration of the alpha-carbon atom. Supplementation does not appear to be useful in adults or children with Crohns disease or inflammatory bowel disease, but clinical studies as of 2016 were underpowered. D-Glutamine is a drug. D-Glutamine exists in all living species, ranging from bacteria to humans. D-Glutamine is a potentially toxic compound. Adverse effects of glutamine have been described for people receiving home parenteral nutrition and those with liver-function abnormalities. Glutamine is the most abundant naturally occurring, nonessential amino acid in the human body, and one of the few amino acids that can directly cross the blood-brain barrier. Glutamine can exist in either of two enantiomeric forms, L-glutamine and D-glutamine. A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia. It is the principal carrier of nitrogen in the body and is an important energy source for many cells. [HMDB] KEIO_ID G006 D-Glutamine is a cell-permeable D type stereoisomer of Glutamine. D-Glutamine is a cell-permeable D type stereoisomer of Glutamine.

   

DL-Glutamine

DL-Glutamine

C5H10N2O3 (146.069139)


DL-Glutamine is used for biochemical research and drug synthesis.

   

(R)-3-Ureidoisobutyrate

(R)-3-Ureidoisobutyrate

C5H10N2O3 (146.069139)


   

Ureidoisobutyric acid

(2S)-3-[(C-Hydroxycarbonimidoyl)amino]-2-methylpropanoate

C5H10N2O3 (146.069139)


Ureidoisobutyric acid, also known as 3-ureidoisobutyrate or beta-UBA, belongs to the class of organic compounds known as ureas. Ureas are compounds containing two amine groups joined by a carbonyl (C=O) functional group. Ureidoisobutyric acid is an extremely weak basic (essentially neutral) compound (based on its pKa). Ureidoisobutyric acid exists in all living organisms, ranging from bacteria to humans. Within humans, ureidoisobutyric acid participates in a number of enzymatic reactions. In particular, ureidoisobutyric acid can be biosynthesized from dihydrothymine through its interaction with the enzyme dihydropyrimidinase. Outside of the human body, ureidoisobutyric acid has been detected, but not quantified in, several different foods, such as bread, squashberries, black elderberries, black crowberries, and climbing beans. This could make ureidoisobutyric acid a potential biomarker for the consumption of these foods. Ureidoisobutyric acid is increased in the urine of patients with beta-ureidopropionase (EC 3.5.1.6) deficiency (PMID: 12271438), a genetic disorder. Ureidoisobutyric acid can be used to predict a patients individual phenotypes of enzyme deficiencies in pyrimidine metabolism when associated with a risk for severe toxicity against the antineoplastic agent 5-fluorouracil (PMID: 12798197).

   

Alanylglycine

{[(2S)-2-ammoniopropanoyl]amino}acetate

C5H10N2O3 (146.069139)


Alanylglycine is a dipeptide composed of alanine and glycine that is found in human urine. It is a breakdown product from endogenous and exogenous proteins. This peptide is generated by dipeptidyl-dipeptidase (or tetrapeptide dipeptidase) which leads to the release of dipeptides from a tetrapeptide (more specifically: Ala-GlyAla-Gly). The enzyme acts more slowly on Ala-AlaAla-Ala and Gly-GlyGly-Gly.

   

Cyclic Urea

5,6-Dihydroxyhexahydro-2H-1,3-diazepine-2-one

C5H10N2O3 (146.069139)


   

Glycyl-D-Alanine

2-[(2-Amino-1-hydroxyethylidene)amino]propanoate

C5H10N2O3 (146.069139)


   

Glycylsarcosine

2-(2-amino-N-methylacetamido)acetic acid

C5H10N2O3 (146.069139)


   

D-Alanyl glycine

2-{[(2R)-2-amino-1-hydroxypropylidene]amino}acetic acid

C5H10N2O3 (146.069139)


D-alanyl glycine, also known as ag, is a member of the class of compounds known as dipeptides. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. D-alanyl glycine is slightly soluble (in water) and a weakly acidic compound (based on its pKa). D-alanyl glycine can be found in rice, which makes D-alanyl glycine a potential biomarker for the consumption of this food product.

   

GLUTAMINE

l-glutamine-13c5, 15n2, 99 atom \\% 13c, 9

C5H10N2O3 (146.069139)


A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AA - Amino acids and derivatives COVID info from COVID-19 Disease Map, PDB, Protein Data Bank, clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS L-Glutamine (L-Glutamic acid 5-amide) is a non-essential amino acid present abundantly throughout the body and involved in many metabolic processes. L-Glutamine provides a source of carbons for oxidation in some cells[1][2]. L-Glutamine (L-Glutamic acid 5-amide) is a non-essential amino acid present abundantly throughout the body and involved in many metabolic processes. L-Glutamine provides a source of carbons for oxidation in some cells[1][2]. L-Glutamine (L-Glutamic acid 5-amide) is a non-essential amino acid present abundantly throughout the body and involved in many metabolic processes. L-Glutamine provides a source of carbons for oxidation in some cells[1][2].

   
   

4-Ureido-butyric acid

4-Ureido-butyric acid

C5H10N2O3 (146.069139)


   

Glycyl-dl-alanine

Glycyl-dl-alanine

C5H10N2O3 (146.069139)


   

Allophanic acid propyl ester

Allophanic acid propyl ester

C5H10N2O3 (146.069139)


   

threo-6-amino-5-hydroxy-5-methyl-1,3-oxazinan-4-one

threo-6-amino-5-hydroxy-5-methyl-1,3-oxazinan-4-one

C5H10N2O3 (146.069139)


   
   

L-Glutamine

l-glutamine-13c5, 15n2, 99 atom \\% 13c, 9

C5H10N2O3 (146.069139)


An alpha-amino acid that consists of butyric acid bearing an amino substituent at position 2 and a carbamoyl substituent at position 4. Glutamine (symbol Gln or Q)[4] is an α-amino acid that is used in the biosynthesis of proteins. Its side chain is similar to that of glutamic acid, except the carboxylic acid group is replaced by an amide. It is classified as a charge-neutral, polar amino acid. It is non-essential and conditionally essential in humans, meaning the body can usually synthesize sufficient amounts of it, but in some instances of stress, the body's demand for glutamine increases, and glutamine must be obtained from the diet.[5][6] It is encoded by the codons CAA and CAG. It is named after glutamic acid, which in turn is named after its discovery in cereal proteins, gluten.[7] In human blood, glutamine is the most abundant free amino acid.[8] The dietary sources of glutamine include especially the protein-rich foods like beef, chicken, fish, dairy products, eggs, vegetables like beans, beets, cabbage, spinach, carrots, parsley, vegetable juices and also in wheat, papaya, Brussels sprouts, celery, kale and fermented foods like miso. The one-letter symbol Q for glutamine was assigned in alphabetical sequence to N for asparagine, being larger by merely one methylene –CH2– group. Note that P was used for proline, and O was avoided due to similarity with D. The mnemonic Qlutamine was also proposed.[7] A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AA - Amino acids and derivatives COVID info from COVID-19 Disease Map, PDB, Protein Data Bank, clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 13 Acquisition and generation of the data is financially supported by the Max-Planck-Society L-Glutamine (L-Glutamic acid 5-amide) is a non-essential amino acid present abundantly throughout the body and involved in many metabolic processes. L-Glutamine provides a source of carbons for oxidation in some cells[1][2]. L-Glutamine (L-Glutamic acid 5-amide) is a non-essential amino acid present abundantly throughout the body and involved in many metabolic processes. L-Glutamine provides a source of carbons for oxidation in some cells[1][2]. L-Glutamine (L-Glutamic acid 5-amide) is a non-essential amino acid present abundantly throughout the body and involved in many metabolic processes. L-Glutamine provides a source of carbons for oxidation in some cells[1][2].

   

L-Glutamine

L-Glutamine

C5H10N2O3 (146.069139)


An optically active form of glutamine having L-configuration. L-Glutamine (L-Glutamic acid 5-amide) is a non-essential amino acid present abundantly throughout the body and involved in many metabolic processes. L-Glutamine provides a source of carbons for oxidation in some cells[1][2]. L-Glutamine (L-Glutamic acid 5-amide) is a non-essential amino acid present abundantly throughout the body and involved in many metabolic processes. L-Glutamine provides a source of carbons for oxidation in some cells[1][2]. L-Glutamine (L-Glutamic acid 5-amide) is a non-essential amino acid present abundantly throughout the body and involved in many metabolic processes. L-Glutamine provides a source of carbons for oxidation in some cells[1][2].

   

D-Glutamine

D-Glutamine

C5H10N2O3 (146.069139)


The D-enantiomer of glutamine. D-Glutamine is a cell-permeable D type stereoisomer of Glutamine. D-Glutamine is a cell-permeable D type stereoisomer of Glutamine.

   

delta-Hydroxylysine

delta-Hydroxylysine

C5H10N2O3 (146.069139)


   
   
   

Asparagine methyl ester

Asparagine methyl ester

C5H10N2O3 (146.069139)


   

Glutamine; LC-tDDA; CE10

Glutamine; LC-tDDA; CE10

C5H10N2O3 (146.069139)


   

Glutamine; LC-tDDA; CE20

Glutamine; LC-tDDA; CE20

C5H10N2O3 (146.069139)


   

Glutamine; LC-tDDA; CE30

Glutamine; LC-tDDA; CE30

C5H10N2O3 (146.069139)


   

Glutamine; LC-tDDA; CE40

Glutamine; LC-tDDA; CE40

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid; LC-tDDA; CE10

3-Ureidoisobutyric acid; LC-tDDA; CE10

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid; LC-tDDA; CE20

3-Ureidoisobutyric acid; LC-tDDA; CE20

C5H10N2O3 (146.069139)


   

Glutamine; AIF; CE0; CorrDec

Glutamine; AIF; CE0; CorrDec

C5H10N2O3 (146.069139)


   

Glutamine; AIF; CE10; CorrDec

Glutamine; AIF; CE10; CorrDec

C5H10N2O3 (146.069139)


   

Glutamine; AIF; CE30; CorrDec

Glutamine; AIF; CE30; CorrDec

C5H10N2O3 (146.069139)


   

Glutamine; AIF; CE0; MS2Dec

Glutamine; AIF; CE0; MS2Dec

C5H10N2O3 (146.069139)


   

Glutamine; AIF; CE10; MS2Dec

Glutamine; AIF; CE10; MS2Dec

C5H10N2O3 (146.069139)


   

Glutamine; AIF; CE30; MS2Dec

Glutamine; AIF; CE30; MS2Dec

C5H10N2O3 (146.069139)


   

Glutamine [M+2H-NH4]+; AIF; CE0; MS2Dec

Glutamine [M+2H-NH4]+; AIF; CE0; MS2Dec

C5H10N2O3 (146.069139)


   

Glutamine [M+2H-NH4]+; AIF; CE10; MS2Dec

Glutamine [M+2H-NH4]+; AIF; CE10; MS2Dec

C5H10N2O3 (146.069139)


   

Glutamine [M+2H-NH4]+; AIF; CE30; MS2Dec

Glutamine [M+2H-NH4]+; AIF; CE30; MS2Dec

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid; AIF; CE0; CorrDec

3-Ureidoisobutyric acid; AIF; CE0; CorrDec

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid; AIF; CE10; CorrDec

3-Ureidoisobutyric acid; AIF; CE10; CorrDec

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid; AIF; CE30; CorrDec

3-Ureidoisobutyric acid; AIF; CE30; CorrDec

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid; AIF; CE0; MS2Dec

3-Ureidoisobutyric acid; AIF; CE0; MS2Dec

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid; AIF; CE10; MS2Dec

3-Ureidoisobutyric acid; AIF; CE10; MS2Dec

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid; AIF; CE30; MS2Dec

3-Ureidoisobutyric acid; AIF; CE30; MS2Dec

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid [M+H-H2O]+; AIF; CE0; MS2Dec

3-Ureidoisobutyric acid [M+H-H2O]+; AIF; CE0; MS2Dec

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid [M+H-H2O]+; AIF; CE10; MS2Dec

3-Ureidoisobutyric acid [M+H-H2O]+; AIF; CE10; MS2Dec

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid [M+H-H2O]+; AIF; CE30; MS2Dec

3-Ureidoisobutyric acid [M+H-H2O]+; AIF; CE30; MS2Dec

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid [M+H-H2O]+; AIF; CE0; CorrDec

3-Ureidoisobutyric acid [M+H-H2O]+; AIF; CE0; CorrDec

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid [M+H-H2O]+; AIF; CE10; CorrDec

3-Ureidoisobutyric acid [M+H-H2O]+; AIF; CE10; CorrDec

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid [M+H-H2O]+; AIF; CE30; CorrDec

3-Ureidoisobutyric acid [M+H-H2O]+; AIF; CE30; CorrDec

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid; LC-tDDA; CE30

3-Ureidoisobutyric acid; LC-tDDA; CE30

C5H10N2O3 (146.069139)


   

3-Ureidoisobutyric acid; LC-tDDA; CE40

3-Ureidoisobutyric acid; LC-tDDA; CE40

C5H10N2O3 (146.069139)


   

Ala-gly

2-(2-aminopropanoylamino)acetic acid

C5H10N2O3 (146.069139)


A dipeptide formed from L-alanyl and glycine residues.

   

Glutamine (D)_major

Glutamine (D)_major

C5H10N2O3 (146.069139)


   

Glutamine (L)_major

Glutamine (L)_major

C5H10N2O3 (146.069139)


   

Glutamine (D)_57.3\\%

Glutamine (D)_57.3\\%

C5H10N2O3 (146.069139)


   
   
   

2-Imidazolidinone,1,3-bis(hydroxymethyl)-

2-Imidazolidinone,1,3-bis(hydroxymethyl)-

C5H10N2O3 (146.069139)


   

beta-Aspartyl methylamide

beta-Aspartyl methylamide

C5H10N2O3 (146.069139)


   

gly-d-ala

Glycyl-D-Alanine

C5H10N2O3 (146.069139)


   

3-Pyridazinecarboxylicacid,hexahydro-5-hydroxy-(9CI)

3-Pyridazinecarboxylicacid,hexahydro-5-hydroxy-(9CI)

C5H10N2O3 (146.069139)


   

1,3-Dimethyl-4,5-dihydroxy-2-imidazolidinone

1,3-Dimethyl-4,5-dihydroxy-2-imidazolidinone

C5H10N2O3 (146.069139)


   
   

2-(dimethylcarbamoylamino)acetic acid

2-(dimethylcarbamoylamino)acetic acid

C5H10N2O3 (146.069139)


   

beta-Alanylglycine

beta-Alanylglycine

C5H10N2O3 (146.069139)


   
   

Glycine,N-(aminocarbonyl)-, ethyl ester

Glycine,N-(aminocarbonyl)-, ethyl ester

C5H10N2O3 (146.069139)


   

H-Gly-Ala-OH

Glycyl-L-alanine

C5H10N2O3 (146.069139)


   

Methyl D-asparaginate

Methyl D-asparaginate

C5H10N2O3 (146.069139)


   
   

L-Glutamine (alpha-15N)

L-Glutamine (alpha-15N)

C5H10N2O3 (146.069139)


   

Ethyl malonyl hydrazide

Ethyl malonyl hydrazide

C5H10N2O3 (146.069139)


   

D-Isoglutamine

(R)-4,5-Diamino-5-oxopentanoic acid

C5H10N2O3 (146.069139)


   

N-Nitroso-N-methyl-4-aminobutyric acid

N-Nitroso-N-methyl-4-aminobutyric acid

C5H10N2O3 (146.069139)


A nitrosamine that has methyl and 3-carboxypropyl substituents. It is a tobacco-derived nitrosamino acid that is a known animal and potential human carcinogen. It induces bladder transitional cell carcinomas in rats and has recently been identified as a contaminant in certain blood pressure medications.

   

Aspartic acid methyl ester

Aspartic acid methyl ester

C5H10N2O3 (146.069139)


   

Alanylglycine

Alanylglycine

C5H10N2O3 (146.069139)


Alanylglycine is a dipeptide found in human urine. It is a breakdown product from endogenous and exogenous proteins. This peptide is generated by dipeptidyl-dipeptidase (or tetrapeptide dipeptidase which leads to the release of dipeptides from a tetrapeptide, more specifically: Ala-GlyAla-Gly. The enzyme acts more slowly on Ala-AlaAla-Ala and Gly-GlyGly-Gly. [HMDB]

   

(2R)-5-amino-2-azaniumyl-5-oxopentanoate

(2R)-5-amino-2-azaniumyl-5-oxopentanoate

C5H10N2O3 (146.069139)


   

(2S)-5-amino-2-ammonio-5-oxopentanoate

(2S)-5-amino-2-ammonio-5-oxopentanoate

C5H10N2O3 (146.069139)


   

Glycylsarcosine zwitterion

Glycylsarcosine zwitterion

C5H10N2O3 (146.069139)


   

(4S)-5-amino-4-azaniumyl-5-oxopentanoate

(4S)-5-amino-4-azaniumyl-5-oxopentanoate

C5H10N2O3 (146.069139)


   
   

2-[Carbamoyl(methyl)amino]propanoic acid

2-[Carbamoyl(methyl)amino]propanoic acid

C5H10N2O3 (146.069139)


   

(2S)-2-(2-Acetylhydrazino)propanoic acid

(2S)-2-(2-Acetylhydrazino)propanoic acid

C5H10N2O3 (146.069139)


   

(2R)-2-[carbamoyl(methyl)amino]propanoic acid

(2R)-2-[carbamoyl(methyl)amino]propanoic acid

C5H10N2O3 (146.069139)


   

beta-Ureidoisobutyric acid

beta-Ureidoisobutyric acid

C5H10N2O3 (146.069139)


   
   

{[(2S)-2-ammoniopropanoyl]amino}acetate

{[(2S)-2-ammoniopropanoyl]amino}acetate

C5H10N2O3 (146.069139)


   

N(4)-methyl-L-asparagine

N(4)-methyl-L-asparagine

C5H10N2O3 (146.069139)


An N-methyl-L-asparagine with a single methyl substituent attached to the amide nitrogen.

   

D-glutamine zwitterion

D-glutamine zwitterion

C5H10N2O3 (146.069139)


Zwitterionic form of D-glutamine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.

   

D-Ala-Gly

D-Ala-Gly

C5H10N2O3 (146.069139)


A dipeptide formed from D-alanine and glycine residues.

   

Gly-ala

Gly-ala

C5H10N2O3 (146.069139)


A dipeptide formed from glycine and L-alanine residues.

   

Ala-Gly zwitterion

Ala-Gly zwitterion

C5H10N2O3 (146.069139)


A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Ala-Gly.

   

3-Ureidoisobutyric acid

3-Ureidoisobutyric acid

C5H10N2O3 (146.069139)


A ureidocarboxylic acid that is 2-methylpropanoic acid substituted by a carbamoylamino group at position 3.

   

L-glutamine zwitterion

L-glutamine zwitterion

C5H10N2O3 (146.069139)


An amino acid zwitterion arising from transfer of a proton from the carboxy to the amino group of L-glutamine; major species at pH 7.3.